Consumer DiscretionaryTextiles & ApparelsOther Textile Products

Trident Texofab Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 27 filings·Updated 24 Aug 2026
Showing 10 of 27 filings.
24 Aug 20261 filing
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Hardik Desai Family Trust acquires Trident Texofab Ltd shares in open market.

Transaction summary

  • Target: Trident Texofab Ltd; Acquirer: Hardik Desai Family Trust (Promoter Group); Open Market.
  • Pre-Transaction voting shares: 10,19,691 (6.79%).
  • Acquired: 5,000 and 15,000 voting shares; Open Market; 20.05.2020.
  • Post-Transaction voting shares: 10,33,591 (6.89%).
  • Equity share capital before/after: Rs 14,99,57,640.
  • Date: 20.05.2020.
Filed 10:08View Source
20 Aug 20261 filing
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Promoter Group Hardik Desai Family Trust acquires 39,425 Trident Texofab shares on open market (17 Aug 2026).

Key details

  • Target Company: Trident Texofab Limited.
  • Disclosing Party: Hardik Desai Family Trust (Promoter Group).
  • Transaction Type: Acquisition of 39,425 voting rights via Open Market.
  • Pre-Transaction Holding: 9,79,266 voting rights; 39,425 encumbered; 6.53% of diluted capital.
  • Post-Transaction Holding: 1,018,691 voting rights; 6.79% of diluted capital.
  • Date of Transaction: 17.08.2026.
  • Capital context: Pre/post equity capital Rs 14,99,57,640; diluted post 1,49,95,764 shares.
Filed 15:43View Source
12 Aug 20261 filing
Company UpdateNewspaper Publication

Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on 12th August, ....

Filed 16:12View Source
10 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Trident Texofab approves Q1 FY2026-27 unaudited results; auditor resignation, internal auditor appointment, and warrants cancellation.

Financial results

  • Unaudited standalone quarterly results for the quarter ended 30 June 2026 approved.
  • Revenue from operations for quarter ended 30 June 2026: 2,614.26.
  • Single segment: Manufacturing & Wholesale (Trading) of Grey cloth.

Auditor changes

  • Resignation of M/s Shah Kailash & Associates LLP as statutory auditor effective 10 August 2026.
  • Board to consider appointment of new statutory auditors for casual vacancy; timing to be intimated.

Internal audit and warrants

  • Internal auditor appointed: M/s Prit Agrawal & Co for FY2026-27; effective 10 August 2026.
  • Warrants cancellation due to expiry of conversion period; Board approved on July 2, 2026.
  • Investor complaints status: Nil as of June 30, 2026.
Filed 20:24View Source
10 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Regulation 74(5) certificate confirms dematerialisation/rematerialisation details furnished to stock exchanges

Dematerialisation/rematerialisation status

  • Details of dematerialised/rematerialised securities for the quarter furnished to stock exchanges.
Filed 11:32View Source
6 Jul 20261 filing
Company UpdateCredit Rating

CRISIL Downgrades Trident Texofab Bank Facilities to CRISIL B/Stable

Rating Action & Outlook

  • Downgrade to CRISIL B/Stable from CRISIL B+/Stable; Outlook Stable.

Instruments Rated

  • Cash Credit (Axis Bank): CRISIL B/Stable
  • Long-Term Loan (Axis Bank): CRISIL B/Stable
  • Proposed Fund-Based Bank Limits (Axis Bank): CRISIL B/Stable
  • Working Capital Term Loan (Axis Bank): CRISIL B/Stable

Rating Agency

  • CRISIL Ratings

Date of Rating Action

  • Credit rating action dated 06 July 2026.
Filed 18:11View Source
2 Jul 20261 filing
OthersOutcome without intimation

Trident Texofab forfeits 9,11,479 warrants; no equity shares issued, capital unchanged

Warrant forfeiture and capital impact

  • Board approved forfeiture of 9,11,479 warrants due to non-exercise.
  • Upfront amount forfeited: Rs 1,59,50,882.50 (25% of issue price).
  • Warrants lapsed and canceled; no equity shares issued.
  • No change in paid-up equity share capital.
  • Warrants issued on 23.12.2024 at Rs 70 each; preferential to non-promoters/public.
  • Tenure: 18 months from allotment; expiry 22.06.2026.
Filed 17:24View Source
16 Apr 20261 filing
Company UpdateGeneral

This is with reference to your email dated 15th April, 2026 and Letter No. L/SURV/ONL/PV/APJ/ 2026-2027 / 3730 received from BSE seeking clarification regarding the significant movement ....

Filed 16:56View Source
15 Apr 20261 filing
Company UpdateClarification

The Exchange has sought clarification from Trident Texofab Ltd on April 15, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....

Filed 19:05
30 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect ....

Filed 18:29View Source
Showing 10 of 27 filings